不可手术腹部/腹膜后软组织肉瘤接受曲贝替定治疗的CT反应模式及CT纹理特征的作用
31例不可手术腹部/腹膜后软组织肉瘤患者接受曲贝替定三线治疗,于2008年10月至2017年7月行基线和随访增强CT。按改良CHOI标准9例部分缓解、10例疾病稳定、12例疾病进展;RECIST 1.1分类为5例部分缓解、15例疾病稳定、11例疾病进展。肿瘤液化是常见反应模式(6/31,19.3%),可导致假性进展,故作者认为应优先采用改良CHOI标准;部分CT纹理特征可辅助预测和监测治疗反应。
要点
- 肿瘤液化是曲贝替定治疗后常见反应模式(6/31,19.3%),可表现为假性进展。
- 作者认为改良CHOI标准优于RECIST 1.1用于该治疗反应评估。
- 基线CT纹理特征平均异质性阈值0.12预测反应:敏感度89%、特异度77%。
核心结论
- 曲贝替定治疗后肿瘤液化是常见反应模式并导致假性进展,故作者认为应优先采用改良CHOI标准;单个CT纹理特征可辅助预测和监测治疗反应。
研究设计与样本
- 回顾性分析31例(女18例、男13例;平均年龄58.0岁,范围38-79岁)接受曲贝替定三线治疗的肉瘤患者,于2008年10月至2017年7月行基线和随访增强CT;反应评估基于改良CHOI标准和RECIST 1.1,分为部分缓解、疾病稳定、疾病进展;CT纹理分析计算均值、熵、强度均匀性/偏度/共生矩阵熵及邻域灰度依赖矩阵对比度。
关键影像表现/征象
- 肿瘤液化是常见反应模式(6/31,19.3%)。
- 出现液化时基线平均强度和平均值较高(p=0.03;p=0.02),而平均偏差较低(p=0.02)。
诊断标准与关键数值
- 改良CHOI标准:9例部分缓解、10例疾病稳定、12例疾病进展。
- RECIST 1.1:5例部分缓解、15例疾病稳定、11例疾病进展。
- 基线CT纹理分析平均异质性阈值0.12预测反应:敏感度89%、特异度77%。
临床应用与阅片要点
- 作者认为应优先采用改良CHOI标准评估曲贝替定治疗反应。
- 单个CT纹理特征可辅助预测和监测治疗反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To evaluate CT patterns and textural features of soft tissue sarcomas following trabectedin therapy as well as their suitability for predicting therapeutic response.
MATERIAL AND METHODS: A total of 31 patients (18 female, 13 male; mean age, 58.0years; range, 38-79years) with sarcoma under trabectedin as a third-line therapy between October 2008 and July 2017 underwent baseline and follow-up contrast-enhanced CT. Response evaluation was based on modifiedCHOI-criteria and RECIST1.1, classified as partial response(PR), stable disease(SD), progressive disease(PD). For CT-texture analysis (CTTA), mean, entropy and uniformity of intensity/skewness/entropy of co-occurrence matrix (COM) and contrast of neighboring-grey-level-dependence-matrix (NGLDM) were calculated.
RESULTS: Following CHOI-criteria, 9 patients achieved PR, 10 SD and 12 PD. RECIST1.1. classified patients into 5 PR, 15 SD and 11 PD. A frequent (n = 6/31; 19.3%) pattern of response was tumor liquefaction. In responders differences in entropy of entropy-NGLDM(p = 0.028) and uniformity-NGLDM(p = 0.021), in non-responders entropy of average(p = 0.039), deviation(p = 0.04) and uniformity of deviation(p = 0.013) occured between baseline and follow-up. Mean intensity and average were higher when liquefication occured(p = 0.03; p = 0.02), whereas mean deviation was lower(p = 0.02) at baseline compared to other response patterns. Differences in mean(p = 0.023), entropy(p = 0.049) and uniformity(p = 0.023) of entropy-NGLDM were found between responders and non-responders at follow-up. For the mean of heterogeneity a cut-off value was calculated for prediction of response in baseline CTTA (0.12; sensitivity 89%; specificity 77%).
CONCLUSION: A frequent pattern of response to trabectedin was tumor liquefication being responsible for pseudoprogression, therefore modifiedCHOI should be preferred. Single CT-textural features can be used complementarily for prediction and monitoring response to trabectedin.
引用
- Esser M, Kloth C, Thaiss WM, et al. CT-response patterns and the role of CT-textural features in inoperable abdominal/retroperitoneal soft tissue sarcomas treated with trabectedin. Eur J Radiol. 2018. PMID: 30292263. doi:10.1016/j.ejrad.2018.09.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。